Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Singer Nicholas Jason
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-12-02
Purchase
2022-12-06
6:52 pm
Eterna Therapeutics Inc.ERNASinger Nicholas Jason
Director
283,286$3.28$929,178832,786
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-08-01
Option Award
2022-08-03
8:01 pm
N/A
2032-08-01
Brooklyn ImmunoTherapeutics Inc.BTXSinger Nicholas Jason
Director
311,900$0311,900
(Direct)
View
2022-06-05
Ownership
2022-06-07
9:08 pm
N/A
N/A
Brooklyn ImmunoTherapeutics Inc.BTXSinger Nicholas Jason
Director
0$02,095,000
(Indirect)
View
2022-05-20
Conversion
2022-05-20
4:35 pm
N/A
N/A
OTR Acquisition Corp.OTRASinger Nicholas Jason
Chief Executive Officer
421,759$0843,518
(Indirect)
View
2022-05-20
Other
2022-05-20
4:35 pm
N/A
N/A
OTR Acquisition Corp.OTRASinger Nicholas Jason
Chief Executive Officer
2,490,311$0843,518
(Indirect)
View
2022-05-06
Other
2022-05-10
08:52 am
N/A
N/A
OTR Acquisition Corp.OTRASinger Nicholas Jason
Chief Executive Officer
10% Owner
5,939,284$02,490,311
(Indirect)
View
2021-03-25
Ownership
2021-04-05
9:46 pm
N/A
N/A
Brooklyn ImmunoTherapeutics Inc.BTXSinger Nicholas Jason
Director
0$03,791,983
(Indirect)
View
2020-11-17
Ownership
2020-11-17
8:58 pm
N/A
N/A
OTR Acquisition Corp.OTRAUSinger Nicholas Jason
Chief Executive Officer
0$02,875,000
(Indirect)
View